Man Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
+41,711
| New | +$152K | ﹤0.01% | 1868 |
|
|
2022
Q4 | – | Sell |
-43,873
| Closed | -$14K | – | 1986 |
|
|
2022
Q3 | $14K | Buy |
+43,873
| New | +$14K | ﹤0.01% | 1909 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1959 |
|
|
2021
Q2 | – | Sell |
-23,759
| Closed | -$80K | – | 1858 |
|
|
2021
Q1 | $80K | Sell |
23,759
-119,047
| -83% | -$401K | ﹤0.01% | 1806 |
|
|
2020
Q4 | $400K | Sell |
142,806
-4,732
| -3% | -$13.3K | ﹤0.01% | 1596 |
|
|
2020
Q3 | $370K | Sell |
147,538
-20,275
| -12% | -$50.8K | ﹤0.01% | 1586 |
|
|
2020
Q2 | $2.28M | Sell |
167,813
-51,293
| -23% | -$696K | 0.01% | 1008 |
|
|
2020
Q1 | $1.66M | Sell |
219,106
-121,069
| -36% | -$918K | 0.01% | 956 |
|
|
2019
Q4 | $2.15M | Sell |
340,175
-25,172
| -7% | -$159K | 0.01% | 1307 |
|
|
2019
Q3 | $1.43M | Sell |
365,347
-569,303
| -61% | -$2.23M | 0.01% | 1340 |
|
|
2019
Q2 | $4.52M | Buy |
934,650
+346,242
| +59% | +$1.68M | 0.02% | 984 |
|
|
2019
Q1 | $4.82M | Buy |
588,408
+190,604
| +48% | +$1.56M | 0.02% | 937 |
|
|
2018
Q4 | $2.2M | Buy |
397,804
+91,685
| +30% | +$507K | 0.01% | 1167 |
|
|
2018
Q3 | $2.7M | Buy |
306,119
+81,900
| +37% | +$723K | 0.01% | 1275 |
|
|
2018
Q2 | $2.24M | Buy |
224,219
+22,800
| +11% | +$228K | 0.01% | 1308 |
|
|
2018
Q1 | $1.92M | Buy |
+201,419
| New | +$1.92M | 0.01% | 1282 |
|